the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
August 23, 2019 – Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal viral disease characterized by progressive damage or inflammation of the white matter of the brain at multiple locations (i.e., multifocal). It is caused by the JC virus, after …
Therapies that promote progressive multifocal leukoencephalopathy (PML) Read more »
August 06, 1015 – The American Food and Drug Administration (FDA) has just issued a warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking Fingolimod (Gilenya) for …
17. April 2009 – In Ergänzung zu einer früheren Mitteilung in diesem Blog, wonach die Zulassung von Efalizumab [Raptiva] in der Schweiz zum 1. Mai 2009 sistiert wird, hat nun die amerikanische Food and Drug Administration (FDA) in einer Mitteilung …
Efalizumab [Raptiva] vom amerikanischen Markt zurückgezogen Read more »